According to the American Cancer Society, prostate cancer is the second leading cause of death among men in the United States, with approximately 1 in 8 being diagnosed during their lifetime. However, an individual’s risk can vary based on factors like age, race, and family history. African American men and Caribbean men of African ancestry are at significantly higher risk compared to those of other racial and ethnic groups.

WHAT THESE BILLS DO

• H.R.1300/S.297, the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act requires health insurance coverage for evidence-based prostate cancer preventive care and screenings, such as the prostate-specific antigen (PSA) test, without cost-sharing.

WHY THIS MATTERS

• Screening for prostate cancer helps identify the disease in its earliest, most treatable stages, leading to better survival rates.
• African American men and Caribbean men of African ancestry are disproportionately affected by prostate cancer. The PSA Screening for HIM Act ensures they, along with others at high risk, have equal access to early detection.
• By eliminating cost-sharing for PSA screenings, this bill removes financial barriers that prevent people from getting tested.